You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
德意法三国暂停使用阿斯利康疫苗
阿思达克 03-16 09:22
欧洲再多三个国家暂停为民众接种阿斯利康(AZN.US)疫苗。《路透》报道,德国、法国和意大利周一(15日)表示,将暂停接种阿斯利康与牛津大学研发的新冠疫苗,而此前已有多个国家报告疫苗可能存在严重副作用,不过世界卫生组织(WHO)表示并不能证明两者存在联系,希望人们不应恐慌。

丹麦和挪威上周已经暂停接种阿斯利康疫苗,早前报告称有个别个案接种後出现出血、血栓和血小板低的情况。冰岛和保加利亚随後跟进,爱尔兰和荷兰周日亦宣布暂停。另外,西班牙媒体亦引述消息称,该国将暂停使用阿斯利康疫苗至少15天。

世卫总干事谭德塞表示,今日(16日)将召开关於阿斯利康的谘询委员会会议。欧洲药品管理局(EMA)也将於本周召开会议,评估收集到的关於阿斯利康疫苗是否导致接种者血栓栓塞事件的信息。(ek/k)

~

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account